Sales rise 76.59% to Rs 521.96 crore
Sadhana Nitro Chem announced that the Board of Directors of the Company at its meeting held on 24 May 2022 inter alia have recommended the final dividend of Rs 015 per equity Share ie 15Percentage subject to the approval of the shareholders
Sales rise 23.58% to Rs 18.45 crore
Sales rise 23.58% to Rs 18.45 crore
Sales decline 3.18% to Rs 42.56 crore
Sales rise 23.58% to Rs 18.45 crore
Business Wire India Revenue for the Pharmaceuticals grows by 29% in FY22, with strong expansion in Gross Margins PAT up 25% YoY Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the quarter and full year ended March 31, 2022. Financial Highlights: Particulars (INR Crore) FY22 FY21 YoY Revenue 279.39 231.33 +20.8% Gross Profit 83.79 59.19 +41.6% […]

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.